Bristol Myers Squibb Commits to Veeva Vault CRM

22.09.25 16:03 Uhr

Werte in diesem Artikel
Aktien

234,00 EUR -1,80 EUR -0,76%

For next-generation CRM with deep, industry-specific AI agents

PLEASANTON, Calif., Sept. 22, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Bristol Myers Squibb (BMS) has committed to Veeva Vault CRM.

Veeva Systems (PRNewsfoto/Veeva Systems)

"Technology is fundamentally reshaping the way we engage with our customers and the patients they serve," said Greg Meyers, executive vice president, chief digital and technology officer at Bristol Myers Squibb. "We are excited to take the next step in our long-standing relationship with Veeva by using Vault CRM to help transform how healthcare practitioners make informed decisions about the increasingly complex array of innovative medicines available today."

"By embedding AI into every step of the customer journey — from how practitioners receive valuable information about our portfolio to how they engage with our field force — Veeva is ideally positioned to support us in our mission to deliver life-changing medicines to patients worldwide," added Meyers.

"We appreciate the trust and partnership and are committed to supporting Bristol Myers Squibb in their mission to provide medicines that transform the lives of patients with serious diseases," said Veeva CEO Peter Gassner. "With Vault CRM we are delivering the next generation of CRM with embedded AI agents to advance healthcare practitioner engagement and help get the right treatments to patients faster."

Vault CRM is part of the Vault CRM Suite of applications that provide the technology foundation for commercial execution. The first Veeva AI agents for Vault CRM — Pre-call Agent, Content Agent, Free Text Agent, and Voice Agent — are planned for availability in December 2025.

About Veeva Systems
Veeva delivers the industry cloud for life sciences with software, data, and business consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

Veeva Forward-Looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2025, which you can find here (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov.

Contact:
Maria Scurry
Veeva Systems
maria.scurry@veeva.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bristol-myers-squibb-commits-to-veeva-vault-crm-302562120.html

SOURCE Veeva Systems

In eigener Sache

Übrigens: Veeva Systems A und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Veeva Systems A

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Veeva Systems A

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Veeva Systems Inc (A)

Wer­bung

Analysen zu Veeva Systems Inc (A)

DatumRatingAnalyst
28.08.2019Veeva Systems A BuyNeedham & Company, LLC
17.04.2019Veeva Systems A BuyNeedham & Company, LLC
27.02.2019Veeva Systems A BuyNeedham & Company, LLC
05.10.2018Veeva Systems A BuyNeedham & Company, LLC
01.10.2018Veeva Systems A HoldCanaccord Adams
DatumRatingAnalyst
28.08.2019Veeva Systems A BuyNeedham & Company, LLC
17.04.2019Veeva Systems A BuyNeedham & Company, LLC
27.02.2019Veeva Systems A BuyNeedham & Company, LLC
05.10.2018Veeva Systems A BuyNeedham & Company, LLC
24.08.2018Veeva Systems A BuyNeedham & Company, LLC
DatumRatingAnalyst
01.10.2018Veeva Systems A HoldCanaccord Adams
25.11.2015Veeva System a HoldDeutsche Bank AG
04.03.2015Veeva System a HoldDeutsche Bank AG
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Veeva Systems Inc (A) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen